Karikò (Pfizer-Biontech): “Vaccine also useful against Omicron variant”
“The vaccine probably doesn’t protect against infection because we’ve had cases, but maybe it protects against ICU. There are multiple levels of protection: positivity, symptoms, hospitalization, resuscitation. But the situation is constantly changing, very difficult to predict. I see many colleagues making more or less reassuring utterances but they are only speculations. Nobody knows exactly what will happen. But one thing can be said: when the Delta variant was discovered, many people rushed to get vaccinated and did well. Because the more people get vaccinated, the less chance the virus has of evolving and mutating. And therefore to continue to spread ”. He tells the Press Pfizer-Biontech senior vice president Katalin Karikó, the scientist who created the messenger RNA for coronavirus vaccines, adding that to understand if the serum will serve against the Omicron variant, “we need a very large number of data, which to now we don’t have. We will have it in the next few weeks, even in a relatively short time “.
– .
